Table 1. Oligonucleotides used in this study.

Name	Sequence	Use	Reference
AE191	5′-TTTTAGTCAGTGTGGAAAATCTCTAGCAG	HIV-1 U5 end –T (29-mer)	[19]
AE143	5′-ACTGCTAGAGATTTTCCACACTGACTAAAA	HIV-1 U5 minus strand (30-mer)	[19]
AE3652	5′- ACTGCTAGAGATTTTCCACACTGACTAAAAGG	HIV-1 U5 minus strand (32-mer)	[19]
AE3653	5′-CCTTTTAGTCAGTGTGGAAAATCTCTAGCA	HIV-1 U5 end precleaved (30-mer)	[19]
AE3715	5′-GTGATATTGCTGAAGAGCTTG	Integration site sequencing primer 1	This study
AE3717	5′-ATTCCACAGCTGGTTCTTTC	Integration site sequencing primer 2	This study
AE4468	5′-ATTGTCATGGAATTTTGTATATTGATTATCCT	PFV U5 end minus strand (EV54)	[8]
AE4469	5′-AGGATAATCAATATACAAAATTCCATGACA	PFV U5 end preprocessed (EV55)	[8]
AE4474	5′-CAGGGACCCGGGGTACTCAAGAAGGGGGACGCC	WDSV IN PCR primer1	This study
AE4475	5′-GCGCGCAGATCTTAAGAAAGTAGCTGGTTGACTGG	WDSV IN PCR primer2	This study
AE4484	5′-CAGGGACCCGGGTCAGCTATTGATGCAGCCCGG	JSRV IN PCR primer1	This study
AE4485	5′-GCGCGCAGATCTCACTCGTGGGCTCGCTCAGC	JSRV IN PCR primer2	This study
AE4494	5′-CAGGGACCCGGGGCTTTAGAGTCAGCTCAAGAAAGC	MMTV PCR primer1	This study
AE4495	5′-GCGCGCAGATCTTAAGGACCTCCTCCGCTTCGG	MMTV PCR primer 2	This study
AE4503	5′-CGGTGACCCTCAGGTCGGCCGACTGCGGCAT	MMTV U5 end –T (31-mer)	This study
AE4504	5′-CGGTGACCCTCAGGTCGGCCGACTGCGGCA	MMTV U5 end precleaved (30-mer)	This study
AE4505	5′-AATGCCGCAGTCGGCCGACCTGAGGGTCACCG	MMTV U5 end minus strand (32-mer)	This study
AE4506	5′-GCGCGCCATATGCTTGAAGTCCTCTTTCAGGGACCCGATGCACCGGATATGCCAGATACC	Rev-A IN PCR primer1	This study
AE4507	5′-GCGCGCAGATCTTAGGATTTTGCTCGCCTGGTCAAC	Rev-A IN PCR primer2	This study
AE4514	5′-GGACTGAATCCGTAGTACTTCGGTACAACAT	Rev-A U5 end –T (31-mer)	This study
AE4515	5′-GGACTGAATCCGTAGTACTTCGGTACAACA	Rev-A U5 end precleaved (30-mer)	This study
AE4516	5′-AATGTTGTACCGAAGTACTACGGATTCAGTCC	Rev-A U5 end minus strand (32-mer)	This study
AE5193	phospho-5′-CAGGGCGCGTCAGGTGGCACT	pEGFP-C1 PCR primer1	This study
AE5194	phospho-5′-TTTCATAGAAGGCGGCGGTGG	pEGFP-C1 PCR primer2	This study